drugset / Trial / NCT00015457

Amlodipine Plus Botulinum Toxin for Focal Dystonia

NCT00015457

RandomizedCrossoverTriple-blindTreatment

Summary

Objective: To determine if the calcium channel blockers, amlodipine can augment the effect of botulinum toxin injections in the treatment of focal dystonia. Study Population: 20 patients with cervical dystonia Design: Double-bind, placebo-controlled clinical trail. Outcome measures: For patients: dystonia rating scales (Twistrs, Fahn-Marsden dystonia scale, NINDS subjective patient rating scale), and hand grip strength. For healthy volunteers: Amplitude of EDB MEP.

Timeline

Start
2001-04
Primary completion
2009-04
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified
Background Botulinum toxin Protein / enzyme biologic

Indications